Publication & Citation Trends
Publications
0 total
Abstract OT2-05-01: FLEX: 30K Full Transcriptome, Real-World Evidence Database for Early-Stage Breast Cancer, and Investigator-Initiated Protocols
Cited by 0
Semantic Scholar
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline OA
Cited by 714
Semantic Scholar
Assessment of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) cohort by agent in the phase 3 ASCENT study of patients (pts) with metastatic triple-negative breast cancer (mTNBC).
Cited by 5
Semantic Scholar
Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial
Cited by 0
Semantic Scholar
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) OA
Cited by 50
Semantic Scholar
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer OA
Cited by 0
Semantic Scholar
P1.09-40 Metastatic Endometrial Sarcoma Presenting as a Spontaneous Pneumothorax and Masquerading as a Pulmonary Blastoma OA
Cited by 0
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(17)
HER2/EGFR in Cancer Research
(14)
Advanced Breast Cancer Therapies
(11)
PI3K/AKT/mTOR signaling in cancer
(6)
Chronic Lymphocytic Leukemia Research
(5)
Affiliations
Albert Einstein College of Medicine
Montefiore Medical Center
University of Miami
Pontificia Universidad Católica de Chile
New York Medical College